January 14, 2024 – QuidelOrtho Company introduced preliminary unaudited earnings for the fourth quarter ended December 29, 2024. The corporate expects complete reported revenues for the fourth quarter of 2024 to be between roughly $702 million and $707 million, which is inside the vary could be about $702 million to $707 million. according to beforehand introduced 2024 monetary steering, together with Labs income, which can be according to expectations. Anticipated complete reported income within the fourth quarter of 2024 consists of:

• Respiratory reported revenues between roughly $141 million and $143 million

• Non-respiratory reported revenues vary from roughly $561 million to $563 million

The preliminary unaudited earnings described herein are primarily based on administration's preliminary evaluation for the fourth quarter ended December 29, 2024 and are topic to adjustment primarily based on the Firm's completion of the year-end monetary shut technique of the yr.

Proceed studying